Masaru Shimizu

Efficacy of SGLT2 inhibitors as additional treatment in Japanese type 2 diabetic patients: second or third choice?

K. Shimomura, Y. Maejima, M. Fujiwara, 2022, BMC research notes.

Surface translocation of Kir2.1 channel induces IL-1β secretion in microglia

H. Tomita, K. Shimomura, Y. Maejima, 2022, Molecular and Cellular Neuroscience.

Goshajinkigan, a Traditional Japanese Medicine, Suppresses Voltage-Gated Sodium Channel Nav1.4 Currents in C2C12 Cells

K. Hagihara, K. Shimomura, Y. Maejima, 2020, BioResearch open access.

Detection of NUCB2/nesfatin-1 in cerebrospinal fluid of multiple sclerosis patients

K. Shimomura, K. Kanai, Y. Maejima, 2020, Aging.

The deletion of glucagon-like peptide-1 receptors expressing neurons in the dorsomedial hypothalamic nucleus disrupts the diurnal feeding pattern and induces hyperphagia and obesity

K. Shimomura, A. Hazama, Y. Maejima, 2021, Nutrition & Metabolism.

Dose Dependent Effect of Sulfamethoxazole on Inhibiting KATP Channel of Mouse Pancreatic β Cell

Y. Maejima, Masaru Shimizu, Kenju Shimomura, 2023, Dose-response : a publication of International Hormesis Society.

Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion

K. Shimomura, Y. Maejima, Shoko Yokota, 2023, BMC Research Notes.

Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review

Masaru Shimizu, Yuko Maejima, Kenju Shimomura, 2023, Frontiers in public health.